Artificial Intelligence

PropTech leader MRI Software adds 2,000 clients, touting major efficiency gains from its AI-first platform in a record-breaking year for the company.

Hudson Talent Solutions integrates a people-first consultancy, betting that the future of recruiting lies in blending its agentic-AI with human expertise.

After a strong Q4, Amprius launches a strategic roadshow to pitch its high-energy silicon anode batteries to investors and key aerospace and defense players.

A new partnership gives thousands of young athletes in Las Vegas free recovery tech while a unique manufacturing model boosts the local economy.

With its pivotal trial fully enrolled, Liberate Medical’s VentFree device aims to shorten ICU stays, reduce complications, and cut healthcare costs.

With $65M in new funding and a new CEO, Duos is betting big on a $200M NVIDIA GPU deal to become a key player in the booming Edge AI infrastructure market.

From the surface of Mars to Earth's most advanced labs, space-tested positioning tech is enabling breakthroughs in semiconductors, photonics, and biotech.

A novel sputum test could end the trial-and-error approach for millions with chronic respiratory disease, promising a new era of personalized medicine.

The cybersecurity firm's new Arkose Device ID uses AI similarity analysis to persistently track devices, aiming to outsmart sophisticated, AI-powered fraudsters.

Trader Interactive and Roamly are embedding AI insurance into RV Trader, Cycle Trader, and Boatmart, making coverage instant and seamless for buyers.

A new firm is defining the future of AI search optimization, but an investigation into the company raises more questions than answers about its claims.

CTL appoints Dan Rodgers, a finance leader from Nike and PwC, to pivot its financial strategy towards aggressive, sustainable growth in the tech lifecycle market.

MacPaw's Setapp moves beyond its bundle model, offering single-app sales in a strategic pivot that empowers users and courts disgruntled developers.

With a soaring stock and a breakthrough CAR-T therapy, Immix Biopharma is set to capture investor attention. What's behind the hype for its lead drug, NXC-201?

A new report reveals a chasm between executive AI ambition and employee readiness, putting billions in tech investments at risk. Here's why HR is key.

New analytics in the duPont REGISTRY Garage app bring Wall Street-style charts to car collecting, empowering owners to trade passion assets like stocks.

An Atlanta clinic combines lasers, biologics, and AI to challenge traditional joint surgery. Can a new marketing push make it a national alternative?

Texada Software's new AI tool promises to find millions in hidden damage for equipment rental firms, but can it overcome industry skepticism and hurdles?

ECGI Holdings is testing a platform to turn mortgages into digital tokens, a move that could disrupt the $2.2 trillion US mortgage industry. Here's how.

New platform enhancements use 'English-as-Code' to help enterprises move AI from risky pilots to reliable, auditable production systems.